Alectinib eclipses crizotinib for ALK positive lung cancer

Adding a second HER2 targeted medicine may lower chance of invasive breast cancer

Targeted sequencing in endocrine refractory breast cancer

Results from the APHINITY trial of two HER2 targeted agents with chemo

Treating BRCA breast cancer with PARP inhibition

Relieving spinal cord compression symptoms with a single radiation treatment

Implementing new health initiatives in low-resource environments

Halving duration of ADT for high risk prostate cancer patients

New personalised therapies for lung cancer

Findings of a phase I/II study of nivolumab in patients with virus-associated tumours

Nivolumab and ipilimumab for metastatic sarcoma

Selumetinib in children with recurrent or refractory low-grade glioma